# metadata.dc.description.abstract[].value
To the Editor: since the first description of infection caused by β-lactam-resistant Streptococcus pneumoniae, the optimal empirical antibiotic therapy for patients with suspected meningitis caused by this microorganism has remained unknown. Hofmann et al. (Aug. 24 issue)1 reported a 25 percent prevalence of penicillin-resistant S. pneumoniae isolates and a 9 percent prevalence of cephalosporin-resistant isolates among 431 patients with invasive pneumococcal infections in Atlanta. The authors recommended adding vancomycin to the initial therapeutic regimen of patients with suspected pneumococcal meningitis.

# metadata.dc.relation.ispartof[].value
New England Journal of Medicine, 1996, vol. 334, p. 53-55

# metadata.dc.source[].value
Articles publicats en revistes (Ciències Clíniques)